Mr. Ron Nagar reports

TEMPRAMED ANNOUNCES FRANKFURT STOCK EXCHANGE LISTING AND CORPORATE AWARENESS AGREEMENT

Tempramed Technologies Ltd.'s common shares are now listed and trading on the Frankfurt Stock Exchange under the trading symbol 9DY. The company has retained bullVestor Medien GmbH to provide certain marketing services for a period of three months, commencing on Nov. 18, 2025. This news release is made in accordance with the requirements of CSE Policy 7, Investor Relations, Promotional Activity and Other Significant Transactions.

The Frankfurt Stock Exchange is one of the world's largest and most liquid trading venues, providing access to a wide base of institutional and retail investors across Europe. The listing marks an important step in expanding Tempramed's visibility and strengthening its international presence. By listing on the FSE, the company expects to increase trading liquidity and broaden engagement with European investors, particularly in a region recognized for its focus on health care innovation and rapid adoption of medical technologies.

"Listing on the Frankfurt Stock Exchange represents a significant milestone for Tempramed as we expand our presence in the European capital markets," said Ron Nagar, chief executive officer of Tempramed. "We are committed to fostering strong relationships with European investors and believe this listing will help us achieve greater visibility and liquidity across the region."

bullVestor marketing services agreement

bullVestor is arm's length to the company, and the marketing services will include the creation of content, ad groups and display ads, as well as keyword optimization, project management and media distribution, with an objective to generally bring attention to the business of the company.

The company has agreed to pay bullVestor a total fee 130,000 euros (approximately $210,000), which will be paid in two instalments, first payment of 75,000 euros (approximately $120,000) within seven days after the agreement date and 55,000 euros (approximately $90,000) within 30 days after the agreement date. To the knowledge of the company, at the time of entering into the agreement, bullVestor and its principals, directly or indirectly, do not own any common shares or other securities of the company.

"We are excited to partner with bullVestor, a renowned marketing firm in Europe, to enhance our engagement with the investment community," said Ron Nagar, chief executive officer of Tempramed. "We believe bullVestor will amplify our presence in the market as we effectively communicate our story to investors."

About Tempramed Technologies Ltd.

Tempramed is a global leader in innovative, temperature-controlled medication storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, Tempramed develops patented, Food and Drug Administration-registered, space-grade thermal insulation hassle-free devices that work 24/seven for years without charging or external power. With a proven product line including VIVI Cap and VIVI Epi, and a smart technology platform on the horizon, Tempramed enables patients and health care providers to confidently manage temperature-sensitive medications anywhere, anytime. With operations in North America, Europe and Asia, Tempramed is advancing the future of medication protection and adherence.

We seek Safe Harbor.